[1]
2026. THE EFFECT OF SGLT2 INHIBITOR THERAPY ON THE COURSE OF ATRIAL FIBRILLATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE. ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ. 86, 2 (Jan. 2026), 148–150.